10.1c Care Management of Preeclampsia Flashcards
Prevention of Pre-eclampsia
- Low dose aspirin reduces preeclampsia risks
- High risk patients are put on 81mg/day aspirin therapy between 12-28 weeks
Preeclampsia High Risk
- History of preeclampsia
- Multifetal gestation
- Chronic hypertension
- Diabetes (1 or 2)
- Renal Disease
- Autoimmune Diseases (Lupus, Antiphospholipid Syndrome)
Preeclampsia Moderate Risk
- First Pregnancy
- 35+ age
- BMI >30
- Family History
Assessment of Preeclampsia
- BP
- Edema
- DTR
- Proteinuria
Edema
- Dependent edema is located in the lowermost dependent parts of the body with the most hydrostatic pressure.
- Pitting edema (pit usually goes away in 10-30 seconds)
GRADING \+1 = 2mm pit \+2 = 4mm pit \+3 = 6mm pit \+4 = 8mm pit
Deep Tendon Reflexes (DTR)
- Bicep and Patellar Reflex are assessed
- Normal is +2
- Normal result (negative clonus) has no rhythmic oscillations
- Abnormal result (positive clonus) has rhythmic oscillations
Proteinuria
- Collected from 24 hour urine specimen
- > 300mg
- protein/creatinine ratio larger than 0.3
- Dipstick measurement 1+ on 2 occasions
Severe Features of Preeclampsia
- Severe headache (frontal)
- Epigastric pain (heartburn)
- RUQ pain
- Visual Disturbances (scotoma, photophobia, double vision)
Problems experienced with Preeclampsia
- Anxiety
- Management Education (assessments, medications, activity restrictions, plans for L&D)
- Financial concerns
- Injuries related to hypertension, CNS irritability secondary to cerebral edema, vasospasm, decreased renal perfusion
- Fetus risk including disrupted oxygen transfer, IUGR, Placental Abruption, Preterm birth
Gestational Hypertension and Preeclampsia Without Severe Features INTERVENTIONS
- Prior to 37 weeks close monitoring of maternal/fetal status
- Can safely be managed at home
- Vaginal birth is recommended at 37 weeks
- BP of 155/105 or less can have regular diet with no salt restriction
SEEK HELP IF - Abdominal pain
- Significant headache
- Uterine Contractions
- Vaginal Spotting
- Decreased fetal movement
Severe Features
- Headaches/Blurred Vision
- Mental Confusion
- RUQ/Epigastric Pain
- N/V
- SOB
- Decreased Urinary Output
- BP monitored twice a week
Fetal Evaluations
- Daily Fetal Movement Counts
- NST or BPP 1-2 times a week
- Ultrasound for amniotic fluid status and estimated fetal weight
- Doppler blood flow test if IUGR is suspected
Pre-Eclampsia Recommendations
- Activity restriction
- Complete/partial bed rest for the duration of pregnancy
Gestational Hypertension and Preeclampsia with Severe Features
- Hospitalized immediately for thorough examination
- Magnesium sulfate to prevent eclamptic seizures
- If this develops after 34 weeks of gestation, prompt birth is recommended
Maternal Assessment
- BP
- Urine Output
- Cerebral Status
- Epigastric/RUQ Pain
- Labor/Vaginal Bleeding
LABS
- Platelets
- Liver Enzymes
- Serum Creatinine
Fetal Assessment
- FHR
- BPP
- Ultrasound (fetal growth and amniotic fluid volume)
- If Fetal Growth Restriction is seen then Doppler is recommended
Expectant Management
- For those who are less than 34 weeks pregnant and no indications for giving birth early
- Hospitalized immediately at a tertiary care facility
Expectant Management
- Oral hypertensive medication (Maintain BP between 140-155/90-105
- Ongoing maternal/fetal assessments
- Corticosteroids to enhance fetal lung maturation
- Betamethasone 12mg IM (2 doses 24 hour intervals)
- Dexamethasone IM 6mg 4 doses 12 hours apart
- Benefits of corticosteroids are best if given before 48 hours of birth
Intrapartum Care
- Early identification of FHR abnormalities
- Prevention of complications
- Continuous FHR and UC monitoring
ASSESSMENTS
- Placental abruption (tense and tender uterus)
- CNS, Cardiovascular, Pulmonary, Hepatic, Renal systems
- VS
Intrapartum Care Preeclampsia (Severe)
- Bed rest with side rails up
- Quiet and dark environment
- Emergency drug/oxygen/suction available
- Reduce risk of pulmonary edema by keeping IV and oral fluids less than 125 mL/hr
Swan-Ganz
- This is a pulmonary artery catheter to evaluate central venous and pulmonary artery pressure
- Used for intensive hemodynamic monitoring
- Only used for select women with preeclampsia (severe) such as those with oliguria
Risks of Preeclampsia (severe)
Maternal
- Eclampsia
- Acute Tubular Necrosis
- Oliguria
- Pulmonary Edema
- Coagulopathy
- Cardiac/Liver Failure
- Subcapsular Hematoma (Hematoma in Liver)
- Cerebral Edema/Hemorrhage
Baby
- IUGR
- Decreased Amniotic Fluid Volume
- Abnormal Fetal Oxygenation
- LBW
- Preterm Birth
Nursing Intervention Preeclampsia (Severe)
- IV line
- Magnesium Sulfate and Antihypertensives (as prescribed)
- Assess BP/Pulse/RR/DTR/LOC/Fetal Status
- Indwelling catheter to measure urine output accurately
- Monitor Headache/Visual/Epigastric Pain
CNS Irritability Outcomes/Interventions
- Woman will maintain DTR 2+ with absence of clonus and no seizures
- Assess VS/LOC/DTR/IV Rate/I&O/Proteinuria
- Initiate seizure precautions with magnesium sulfate.
- Make sure oxygen and suction is readily available
- Report signs of worsening conditions (headache, visual changes, RUQ pain)
Decreased Tissue Perfusion Outcome/Interventions
- Women should maintain good perfusion (adequate urine output, normal HR)
- Assess BP, IV Fluid Intake, Indwelling Catheter, Breath Sounds, Edema, FHR
- Administer Antihypertensives as prescribed
- Bed Rest in Side Lying Position
Decreased Gas Exchange Outcome/Interventions
- Exhibit Normal Gas Exchange (normal breath sounds, RR, full orientation to person/place/time)
- Assess color, capillary refill, breath sounds, increased RR, dyspnea, oxygen saturation
- Notify HCP for signs of impaired gas exchange where oxygen and diuretics will be administered
- Educate women on doing turn-cough and taking deep breaths
Magnesium Sulfate
- Prevents seizures (CNS Depressant)
- Loading dose 4-6g infused over 15-30 minutes
- Maintenance dose diluted into IV fluid (40g in 1000mL lactated ringer)
- Administered via Infusion Pump 2-3g an hour
- Does not affect BP
- Magnesium Sulfate works through vasodilation in peripheral and cerebral circulation which prevents cerebral edema and acts as an anticonvulsant
Magnesium Sulfate Side Effects and Toxicity
Side Effects
- Warm/Flushing/Diaphoresis
- Burning at IV site
- Magnesium is secreted in urine so I&O is important to monitor. Renal failure will cause magnesium toxicity
TOXICITY
- Absent DTR
- Decreased RR
- Decreased LOC
What to Monitor for Magnesium Sulfate
Maternal V/S
FHR
I&O
DTR (Ankle Clonus)
Magnesium Sulfate Toxicity
- Discontinue medication
- Administer calcium gluconate slowly
Control of BP
- Medications used if BP exceeds 160/110
- Goal is to keep BP 140-150/90-100
Medications
- Hydralazine (Apresoline)
- Labetalol (Trandate)
- Nifedipine (Procardia)
PreEclampsia Post-Partum Care
- VS, I&O, DTR, LOC, Magnesium Sulfate Prophylaxis continued for 24 hours
- Preeclampsia usually resolves within 48 hours after birth
- Signs that preeclampsia is resolving is diuresis and reduced edema
- Baby may be taken to NICU
- BP should continue to be monitored for 72 hours because hypertension takes longer to resolve
- BP should be re-assessed 7-10 days after
- If BP remains at 150/100 or greater, antihypertensives should be prescribed